Swiss Helvetia Fund is a non-diversified, closed-end investment company whose objective is to seek long-term capital appreciation through
Business Model:
Revenue: $28.3M
Employees: 51-200
Address: 1270 Avenue of the Americas
City: New York
State: NY
Zip: 10020
Country: US
Swiss Helvetia Fund is a non-diversified, closed-end investment company whose objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The Fund also may acquire and hold equity and equity-linked securities of non-Swiss companies in limited instances.
Contact Phone:
+12128677660
Contact Email:
Listed Exchange:
NYSE
IPO Date:
8/28/1987
Ticker Symbol:
SWZ
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2009 | Synosia Therapeutics | Series B | 0 |
10/2010 | Synosia Therapeutics | Series C | 0 |
8/2015 | Kuros Biosciences | Post-IPO Equity | 15.3M |
1/2012 | Selfrag | Series C | 9.6M |
8/2015 | Kuros Biosciences | Post-IPO Equity | 0 |
1/2012 | Selfrag | Series C | 0 |
10/2010 | Synosia Therapeutics | Series C | 0 |
1/2009 | Synosia Therapeutics | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|